Kuros Biosciences AG EBIT for the year ending December 31, 2024: USD -3.52 M

Kuros Biosciences AG EBIT is USD -3.52 M for the year ending December 31, 2024, a -69.10% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Kuros Biosciences AG EBIT for the year ending December 31, 2023 was USD -11.39 M, a -9.77% change year over year.
  • Kuros Biosciences AG EBIT for the year ending December 31, 2022 was USD -12.62 M, a 40.96% change year over year.
  • Kuros Biosciences AG EBIT for the year ending December 31, 2021 was USD -8.96 M, a -29.50% change year over year.
  • Kuros Biosciences AG EBIT for the year ending December 31, 2020 was USD -12.70 M, a 10.15% change year over year.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)